Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
That's your last free article this week. Create a free account for 4 a week — or go Pro for everything.Go Pro →
Devices & Tech

Ultherapy PRIME Clears FDA for Knee Skin Laxity

Merz expands the first real-time ultrasound platform into a new body-contouring indication.

Image: Inside MedSpa

Merz Aesthetics has secured FDA clearance for Ultherapy PRIME on knee skin laxity, extending the platform's non-surgical lifting footprint beyond the face and neck. The indication leverages PRIME's core advantage—real-time ultrasound visualization during treatment—to guide energy delivery and ensure consistent collagen remodeling in a notoriously difficult anatomical zone.

First and only FDA-cleared ultrasound with real-time visualization for non-surgical skin lifting.

Knee laxity remains underserved in most practices. The area is prone to skin laxity post-weight loss and aging, yet few devices deliver predictable results without invasive surgery. PRIME's ability to visualize tissue depth and energy penetration in real time addresses that gap. The clearance positions Merz to capture a secondary revenue stream in body contouring without requiring new hardware investment from practices already running the system.

Source: original report ↗

Frequently asked questions

Can Ultherapy PRIME treat loose skin on knees?

Yes. Merz Aesthetics just received FDA clearance for Ultherapy PRIME to treat knee skin laxity, making it one of the first real-time ultrasound platforms approved for this indication. The real-time visualization helps guide energy delivery to ensure consistent collagen remodeling in this difficult anatomical area.

What makes Ultherapy PRIME different for knee skin tightening?

PRIME's core advantage is real-time ultrasound visualization during treatment, which allows practitioners to see tissue depth and monitor energy penetration as it happens. This precision is especially valuable for knees, where skin laxity is notoriously difficult to treat predictably without surgery.

Do I need a new machine to offer Ultherapy PRIME knee treatments?

No. Practices already running Ultherapy PRIME can offer knee skin laxity treatments without new hardware investment. The knee indication expands the platform's existing capabilities to capture additional revenue from body-contouring procedures.

Is Ultherapy PRIME better than surgery for knee skin laxity?

PRIME offers a non-surgical alternative that delivers predictable results through real-time ultrasound guidance and collagen remodeling. While it may not match surgical outcomes in severe cases, it fills a significant gap for patients seeking non-invasive lifting without downtime.

When did Ultherapy PRIME get cleared for knees?

Merz Aesthetics recently secured FDA clearance for Ultherapy PRIME on knee skin laxity, though the exact date is not specified in the announcement. This clearance represents the first expansion of the PRIME platform into body-contouring indications beyond the face and neck.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/ultherapy-prime-knee-fda-clearance/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo